Viridian Therapeutics | DEFA14A: Others
Viridian Therapeutics | 10-Q: Quarterly report
Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Viridian Therapeutics | ARS: Annual Report to Security Holders
Viridian Therapeutics | DEFA14A: Others
Viridian Therapeutics | DEF 14A: Definitive information statements
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(18.64%),Fairmount Healthcare Fund II GP LLC(18.64%), etc.
Viridian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Viridian Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Viridian Therapeutics | 10-K: Annual report
Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
Viridian Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Tousignant Jennifer
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.7%),Commodore Capital Master LP(3.7%)
Viridian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tousignant Jennifer
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.90%),Deep Track Biotechnology Master Fund, Ltd.(9.90%), etc.
Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.71%)
No Data